The present invention relates to aminocyclohexanol derivatives useful for
the treatment and/or prophylaxis of diseases which are associated with
2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia,
hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones,
tumors and/or hyperproliferative disorders, and treatment and/or
prophylaxis of impaired glucose tolerance and diabetes.
